GlassScriptPhysician profile
Jonathan P Lindman
NPI 1740242692
$54,592.78
in general payments reported to CMS, 2019-2025
14 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $132 · 2021: $176 · 2022: $598 · 2023: $251 · 2024: $171 · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Food and Beverage: $644 · Consulting Fee: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,750.00 |
| Food and Beverage | $644.01 |
| Consulting Fee | $170.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Snap Diagnostics LLC | $52,750.00 | 2025 | Snap Diagnostics Study |
| Inspire Medical Systems, INC. | $814.71 | 2022-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $215.97 | 2019-2022 | |
| Medtronic, INC. | $205.00 | 2022-2024 | Straightshot, Merocel, Nuvent |
| Intersect Ent, INC. | $140.82 | 2021-2022 | |
| Glaxosmithkline, LLC. | $110.67 | 2025 | Nucala |
| Genzyme Corporation | $79.43 | 2025 | |
| Optinose US, INC. | $74.83 | 2019-2021 | |
| Kaleo, INC. | $60.49 | 2019-2021 | |
| Acclarent, INC | $46.64 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $33.23 | 2021 | |
| Spirair, INC. | $26.70 | 2024 | Septalign |
| Blueprint Medicines Corporation | $22.03 | 2023 | Ayvakit |
| Harmony Biosciences LLC | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lindman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.